The EBRD lends €20M to Ukrainian pharmaceutical company Farmak.
Friday, May 27, 2022

The EBRD lends €20M to Ukrainian pharmaceutical company Farmak.

 The EBRD is lending €20M to a leading Ukrainian pharmaceuticals manufacturer under its €2B Resilience and Livelihoods Framework, supporting countries affected by the war in Ukraine. The financing, which will provide working capital to a manufacturer with a 5.7 % pre-war share of Ukraine’s pharmaceuticals market, will support production and improve access to essential medicines for people living in Ukraine. Supporting the pharmaceutical sector during the war in Ukraine is a crucial element of the bank’s five-pronged support plan for the real economy of Ukraine and the surrounding region. The EBRD also supports trade, energy security, vital infrastructure, and food security.

Previous post
Ukraine wants partner countries to issue state guarantees for investing in Ukraine.

Ukraine wants partner countries to issue state guarantees for investing in Ukraine.

Next post
Ukraine's international reserves in May stand at $27B.

Ukraine's international reserves in May stand at $27B.

Previous Main Topics